@xconomy.com 5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas